Skip to main content
Premium Trial:

Request an Annual Quote

OpGen Raises $17M to Market Optical Mapping System

Premium

This story was originally published Sept. 27

OpGen, a commercial provider of optical restriction-mapping technology, has raised $17 million in Series B financing.

The financing adds to $23.6 million that the company raised in a Series A round in 2007 (IS 9/21/2007). The Series B was led by jVen Capital with participation from the company's other major investors, including CHL Medical Partners, Highland Capital Partners, Mason Wells Biomedical, and Versant Ventures. In addition, Evan Jones, the managing member of jVen Capital, has been named executive chairman of OpGen's board of directors.

OpGen's commercial optical mapping system, which was launched this June for microbial genome analysis, is an automated technology for generating maps that can be used in strain typing, comparative genomics, and sequence assembly.

The new funding will support marketing for the technology, dubbed the Argus Optical Mapping System. It will also "fuel our efforts to expand into new markets, including the development of new applications that will complement sequencing technologies and help facilitate rapid completion of large genome mapping and finishing technologies currently under development at the company," OpGen's CEO Douglas White said in a statement.

According to the company, the Argus system will have a wide range of applications in fields such as biodefense, outbreak management, agriculture, and clinical microbiology.

OpGen's customers include biodefense organizations, genomic research centers, academic institutions, clinical research organizations, and biotechnology companies.

The Scan

Wolf Howl Responses Offer Look at Vocal Behavior-Related Selection in Dogs

In dozens of domestic dogs listening to wolf vocalizations, researchers in Communication Biology see responses varying with age, sex, reproductive status, and a breed's evolutionary distance from wolves.

Facial Imaging-Based Genetic Diagnoses Appears to Get Boost With Three-Dimensional Approach

With data for more than 1,900 individuals affected by a range of genetic conditions, researchers compared facial phenotype-based diagnoses informed by 2D or 3D images in the European Journal of Human Genetics.

Survey Suggests Multigene Cancer Panel VUS Reporting May Vary Across Genetic Counselors

Investigators surveyed dozens of genetic counselors working in clinical or laboratory settings, uncovering attitudes around VUS reporting after multigene cancer panel testing in the Journal of Genetic Counseling.

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.